Improved Targeting of Cancers with Nanotherapeutics
Author:
Publisher
Springer New York
Link
http://link.springer.com/content/pdf/10.1007/978-1-4939-6646-2_2
Reference164 articles.
1. Ratain MJ (2015) Redefining the primary objective of phase I oncology trials. Nat Rev Clin Oncol 12(3):126
2. Thanarajasingam G, Hubbard JM, Sloan JA, Grothey A (2015) The imperative for a new approach to toxicity analysis in oncology clinical trials. J Natl Cancer Inst 107(10):djv216
3. Weiner GJ (2015) Building better monoclonal antibody-based therapeutics. Nat Rev Cancer 15(6):361–370
4. Scott AM, Wolchok JD, Old LJ (2012) Antibody therapy of cancer. Nat Rev Cancer 12(4):278–287
5. Khalil DN, Smith EL, Brentjens RJ, Wolchok JD (2016) The future of cancer treatment: immunomodulation, CARs and combination immunotherapy. Nat Rev Clin Oncol 13:273–290
Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Non-viral vectors combined delivery of siRNA and anti-cancer drugs to reverse tumor multidrug resistance;Biomedicine & Pharmacotherapy;2024-09
2. Chlorin e6: A Promising Photosensitizer in Photo-Based Cancer Nanomedicine;ACS Applied Bio Materials;2023-01-26
3. Recent progress of rare earth doped hydroxyapatite nanoparticles: Luminescence properties, synthesis and biomedical applications;Acta Biomaterialia;2022-08
4. Targeting nanoparticles to malignant tumors;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2022-05
5. Applications and Biocompatibility of Mesoporous Silica Nanocarriers in the Field of Medicine;Frontiers in Pharmacology;2022-01-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3